Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-07

Clinical Trial Update: Varenicline for Smoking Cessation in Heavy Drinking Smokers [Phase 2]

View source ↗

Summary

Phase 2 trial update of varenicline for smoking cessation in heavy drinking smokers; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Yale University | Conditions: Nicotine Dependence, Smoking | Phase 2 | Status: COMPLETED | Results posted: 2013-03-07